Not all DTC patients with N positive disease deserve the attribution “high risk”. Contribution of the MSDS trial

E-ISSN： 1096-9098|112|1|9-14

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.112, Iss.1, 2015-07, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N‐acetylcysteine and AKI after OPCAB

NEPHROLOGY, Vol. 20, Iss. 2, 2015-02 ,pp. : 96-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are all patients with psoriasis at increased risk for coronary artery disease?

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 3, 2015-03 ,pp. : 355-361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Constipation during acute hospitalisation: vigilance critical for all patients at high risk

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 4, 2015-04 ,pp. : 388-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

HIV-Positive Patients with Liver Metastases from Colorectal Cancer Deserve the Same Therapeutic Approach as the General Population

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 203-204

Karger

Access to resources Recommend Favorite

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

By Harutyunyan Marina J. Mathiasen Anders B. Winkel Per Gøtze Jens P. Hansen Jørgen Fischer Hildebrandt Per Jensen Gorm Boje Hilden Jørgen Jespersen Christian M. Kjøller Erik Kolmos Hans J. Gluud Christian Kastrup Jens

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 1, 2011-02 ,pp. : 52-62

Informa Healthcare

Access to resources Recommend Favorite